Open Access
CC BY-NC-ND 4.0 · AJP Rep 2020; 10(01): e121-e127
DOI: 10.1055/s-0040-1709185
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hepatitis C Virus Infection in Children and Pregnant Women: An Updated Review of the Literature on Screening and Treatments

Autor*innen

  • Rosalia Ragusa

    1   Health Technology Assessment Committee, Health Directorate, University Hospital “G. Rodolico,” Catania, Italy
  • Liberato Simone Corsaro

    2   Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy
  • Evelise Frazzetto

    3   Hepatology Unit, A.O.U. Policlinico-Vittorio Emanuele, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
  • Emanuele Bertino

    4   Department of Drug Sciences, University of Catania, Catania, Italy
  • Maria Alessandra Bellia

    5   School of Medicine, University of Catania, Catania, Italy
  • Gaetano Bertino

    3   Hepatology Unit, A.O.U. Policlinico-Vittorio Emanuele, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy

Funding This study was funded by the 2016/2018 Research Plan of University of Catania, Department of Clinical and Experimental Medicine (project “Early molecular and clinical-instrumental markers in metabolic and chronic-degenerative pathologies”).
Weitere Informationen

Publikationsverlauf

29. Dezember 2019

20. Februar 2020

Publikationsdatum:
31. März 2020 (online)

Abstract

Objective The aim of the paper is to review the current information relating to the diagnosis and treatment of hepatitis C virus (HCV) infection in pregnant women and children, particularly those infected by mother-to-child transmission.

Study Design A review of published literature was performed to identify relevant articles published between January 2015 and March 2019 on: HCV infection in pregnant woman, mother-to child-transmission of HCV and HCV infection in pediatrics. The results of the evaluation of the different studies were summarized in two sections describing separately the screening and effective treatments in pregnant women and children.

Results The rate of mother-to-child transmission of HCV is approximately 5%. HCV infection is strongly associated with cholestasis and preterm birth. Prenatal diagnosis of hepatitis C virus has a dual benefit for mother and child. Perinatally infected children develop cirrhosis in earlier age than those who acquire HCV as adolescents. Pregnant women with cirrhosis have a higher risk of poor maternal and neonatal outcomes than those without cirrhosis.

Conclusion To improve public health, universal screening of pregnant women for HCV infection should be performed. Early identification of women and children with HCV infection is important to enable them to be included in assessment and/or treatment programs.